FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Inspection Finds Zoll Failed to Report Deaths

[ Price : $8.95]

FDA says a June inspection at Zoll Circulations Sunnyvale, CA facility found that the company failed to file MDR reports within 30...

CDRH Waives Refuse-to-Accept Policy Until January 1

[ Price : $8.95]

CDRH says it is waiving its new refuse to accept policy until 1/1/2013 for 510(k)s while industry becomes acclimated to the FDA Sa...

Guidance on BE Studies for Lenalidomide

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance providing recommendations on bioequivalence studies for lenalidomide.

Approvable Letter on LDR Cervical Disc PMA

[ Price : $8.95]

FDA gives LDR an approvable letter for its PMA for the Mobi-C Cervical Disc, a metal and polyethylene mobile bearing prosthesis sp...

Temple: Agency Pretty Excited About Mini-Sentinels Speed

[ Price : $8.95]

CDER deputy Center director for clinical science Bob Temple tells a radio discussion FDAers are pretty excited about the ability o...

Info on Generic Drug User Fees Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on the generic drug user fee cover sheet to the Office o...

NeuroMed Promoting Devices to Treat Herpes: CDRH

[ Price : $8.95]

CDRH warns NeuroMed Devices that it is marketing its Neuro Calm devices for treating herpes without an approved PMA or IDE.

2002 Compounding Outbreak Lessons Not Learned: Critics

[ Price : $8.95]

The Washington Post says that people who were involved in a 2002 compounding pharmacy disease outbreak say that lessons were not l...

Clinical Trials Yield Costly, Extraneous Data: Tufts

[ Price : $8.95]

A Tufts Center for the Study of Drug Development report says that companies are spending on average $1 million for clinical trial ...

Revoke Nitric Oxide Orphan Designation: Ikaria

[ Price : $8.95]

Ikaria petitions FDA to revoke the orphan drug designation approved for GeNOs competing nitric oxide product for treating persiste...